[Primary prevention of esophageal variceal rupture: endoscopic ligation or propranolol?].
Oberti
F
F
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D016145:Endoscopy, Digestive System; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008026:Ligation; D008875:Middle Aged; D011322:Primary Prevention; D011433:Propranolol / Q000627:therapeutic use*; D011446:Prospective Studies; D012307:Risk Factors; D012422:Rupture, Spontaneous / Q000517:prevention & control; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011433:Propranolol
Prophylaxie primaire de la rupture de varices oesophagiennes: ligature endoscopique ou propranolol?